These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog. Leboeuf J; Basiez M; Massingham R Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882 [TBL] [Abstract][Full Text] [Related]
32. Facilitation of reentry by lidocaine in canine myocardial infarction. Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083 [TBL] [Abstract][Full Text] [Related]
33. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart. Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070 [TBL] [Abstract][Full Text] [Related]
34. Time course of changes in ventricular excitability and conduction during myocardial ischemia and reperfusion in the dog: effect of lidocaine. Avitall B; Naimi S; Levine HJ; Mieszala J J Electrocardiol; 1979 Jul; 12(3):271-7. PubMed ID: 89180 [TBL] [Abstract][Full Text] [Related]
35. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction. Hashimoto H; Katoh H; Nakashima M J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695 [TBL] [Abstract][Full Text] [Related]
36. Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction. Aidonidis I; Brachmann J; Rizos I; Toutouzas P; Kübler W Cardiology; 1994; 85(6):378-87. PubMed ID: 7697673 [TBL] [Abstract][Full Text] [Related]
37. Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs. Aidonidis I; Egel E; Hilbel T; Rizos I; Kuebler W; Brachmann J Eur Heart J; 1994 Dec; 15(12):1698-704. PubMed ID: 7698141 [TBL] [Abstract][Full Text] [Related]
38. Effects of lidocaine on impulse formation and conduction defects in man. Roos JC; Dunning AJ Am Heart J; 1975 Jun; 89(6):686-99. PubMed ID: 48330 [TBL] [Abstract][Full Text] [Related]
39. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy. Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296 [TBL] [Abstract][Full Text] [Related]
40. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction. Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]